Processing your request

please wait...

Case Page


Case Status:    DISMISSED    
On or around 01/07/2016 (Date of order of final judgment)

Filing Date: December 04, 2014

According to the law firm press release, Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Sanofi was making improper payments to healthcare professionals in connection with the sale of pharmaceutical products in violation of federal law; (2) Sanofi lacked adequate internal controls over financial reporting; and (3) as a result of the foregoing, Sanofi's public statements were materially false and misleading at all relevant times.

On October 6, 2014, the Company's media relations department issued a statement announcing that the Company was investigating allegations related to improper payments to healthcare workers.

On October 29, 2014, the Company issued a press release and filed a Form 6-K with the SEC, announcing that its Board of Directors had decided to terminate the Chief Executive Officer of Sanofi. As a result of this news, shares of Sanofi fell as much as $2.85 or almost 6%, on unusually heavy volume, to close at $45.22 on October 29, 2014.

On January 6, 2016, the Court issued an Order granting Defendants' motion to dismiss. A Notice of Appeal of this Order was filed on July 25. The Appeal was voluntarily dismissed on November 7.

Protected Content

Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.